PALO ALTO, Calif.--(BUSINESS WIRE)--Now in its 25th year serving the medical device industry, the Wilson Sonsini Goodrich & Rosati Medical Device Conference will be held Friday, June 2, 2017 in San Francisco (www.wsgr.com/news/medicaldevice). Wilson Sonsini Goodrich & Rosati (WSGR) is a long-standing provider of legal services to technology, life sciences, medical, and growth enterprises worldwide (www.wsgr.com/WSGR/Default.aspx).
In a series of topical panels presented over the course of one day, experts and presenters including industry CEOs, industry strategists, venture capitalists, investment bankers, and market analysts will discuss the challenges facing today’s Medtech start-ups and the strategies emerging in response to these challenges.
Topics to be Covered in Depth During the Conference Include:
* New Models for Medtech Investing
* Big Medtech's Evolving Business Development Strategies
* Pacific Rim Deals with U.S. Medtech
* IP Value -- A Corporate and Investor Perspective
* Funding Strategies for Entrepreneurs
* Make America Great Again -- Insights from Washington, D.C.
* University Licensing Strategies
* Structuring Strategic Collaborations
* Clinical Trials -- Avoiding Major Pitfalls
* Making the Case for Value
* IPOs and Mergers
* Collaborations Between Japan and Silicon Valley
* Strategic Positioning to Avoid or Minimize the Risk of Earn-out Disputes
Confirmed Speakers Include Representatives From:
Abbott Ventures, AdvaMed, AZCA Venture Partners, Asahi Kasei Corporation, Brandon Capital Partners, CryoLife, Curation Capital, Deerfield Capital, Element Science, Emergent Medical Partners, Endeavor Vision, Enplas Corporation, ForSight Labs, iRhythm Technologies, Kaiser Permanente, KCK Group, Launchpad Digital Health, LivaNova, Longford Capital Management, M.H. Carnegie & Company, Medeon Biodesign, Medical Device Manufacturers Association (MDMA), Medpass International, Medtronic, Monterey Advisors, MVM, Nevro, Partisan Management Group, Qool Therapeutics, Redmile Group, RCT Ventures, ReThink Medical, Simplify Medical, Spirox, SRS Acquiom, Stanford University, Symap Medical, Teleflex, Terumo Corporation, The Foundry, The MedTech Strategist, TheraNova, U.S.-Japan MedTech Frontiers (USJMF), Xip, and ZOLL Medical Corporation.
Among the highlights of this year's conference is the launch of WSGR’s new Partnering Hall, which will provide personalized opportunities for large Medtech consolidators and investors to meet with medical device and healthcare IT start-ups looking for investment, partnering, and acquisition opportunities.
Partnering Hall is a feature of the conference web app and was created to help facilitate targeted networking and business development opportunities. Investors will have access to detailed executive summaries from start-ups attending the conference and special software that will allow interested parties to arrange one-on-one meetings.
The conference will conclude with a wine tasting reception featuring wines from several California wineries. Local venture capitalists will serve as sommeliers for the event.
Prior-Night Dinner & Keynote -- Michael DeMane, Nevro (Thursday, June 1 2017):
A dinner and keynote interview will be held the evening before the conference, and will feature a conversation with Michael DeMane, chairman of Nevro, an innovative medical device company based in Redwood City, California. DeMane took Nevro public in late 2014 at a $425 million valuation, and in seven short months, he helped grow the company’s value to more than $1 billion. The dinner and interview will take place at the Sharon Heights Golf & Country Club in Menlo Park.
Registration for the conference (including the wine tasting reception) is open to the public (http://www.cvent.com/d/5vqhc4/4W). Tickets to the June 1 dinner and keynote program are not included with conference registration and are available at an additional cost.
For more information about the conference or the new Partnering Hall contact 650-320-4529.